Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1989 Aug 1;141(3):217–221.

Urine citrate and renal stone disease.

H Goldberg 1, L Grass 1, R Vogl 1, A Rapoport 1, D G Oreopoulos 1
PMCID: PMC1269410  PMID: 2665909

Abstract

Calcium stone disease is attributable to supersaturation of the urine with calcium and other salts, the presence of substances that promote crystallization and a deficiency of inhibitors of crystallization. Citrate is a potent inhibitor of calcium oxalate and calcium phosphate stone formation whose excretion is diminished in some patients with stone disease owing to idiopathic causes or secondary factors such as bowel disease and use of thiazides. The pH within the proximal tubule cells is an important determinant of citrate excretion. Multivariate analysis has shown that the urine concentrations of calcium and citrate are the most important factors in stone formation. In uncontrolled studies potassium citrate, which increases urinary citrate excretion, appears to be promising as a therapeutic agent for patients with stone disease and hypocitraturia refractory to other treatment. On the other hand, there are potential drawbacks to sodium alkali therapy, such as the precipitation of calcium phosphates.

Full text

PDF
217

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coe F. L. Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep;24(3):392–403. doi: 10.1038/ki.1983.172. [DOI] [PubMed] [Google Scholar]
  2. Elliot J. S., Ribeiro M. E. The urinary excretion of citric, hippuric, and lactic acid in normal adults and in patients with calcium oxalate urinary calculus disease. Invest Urol. 1972 Jul;10(1):102–106. [PubMed] [Google Scholar]
  3. Ettinger B., Tang A., Citron J. T., Livermore B., Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986 Nov 27;315(22):1386–1389. doi: 10.1056/NEJM198611273152204. [DOI] [PubMed] [Google Scholar]
  4. GAMBLE W., ORTEN J. M., SMITH A. H. Citric acid cycle in certain alterations of acid-base balance in human subjects. J Appl Physiol. 1961 Jul;16:593–596. doi: 10.1152/jappl.1961.16.4.593. [DOI] [PubMed] [Google Scholar]
  5. HODGKINSON A. Citric acid excretion in normal adults and in patients with renal calculus. Clin Sci. 1962 Oct;23:203–212. [PubMed] [Google Scholar]
  6. Hallson P. C., Rose G. A., Sulaiman S. Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Urol Int. 1983;38(3):179–181. doi: 10.1159/000280885. [DOI] [PubMed] [Google Scholar]
  7. Hosking D. H., Erickson S. B., Van den Berg C. J., Wilson D. M., Smith L. H. The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol. 1983 Dec;130(6):1115–1118. doi: 10.1016/s0022-5347(17)51711-5. [DOI] [PubMed] [Google Scholar]
  8. Hosking D. H., Wilson J. W., Liedtke R. R., Smith L. H., Wilson D. M. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis. J Lab Clin Med. 1985 Dec;106(6):682–689. [PubMed] [Google Scholar]
  9. Kok D. J., Papapoulos S. E., Bijvoet O. L. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet. 1986 May 10;1(8489):1056–1058. doi: 10.1016/s0140-6736(86)91329-2. [DOI] [PubMed] [Google Scholar]
  10. Menon M., Mahle C. J. Urinary citrate excretion in patients with renal calculi. J Urol. 1983 Jun;129(6):1158–1160. doi: 10.1016/s0022-5347(17)52618-x. [DOI] [PubMed] [Google Scholar]
  11. Meyer J. L., Thomas W. C., Jr Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. II. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium oxalate crystal growth. J Urol. 1982 Dec;128(6):1376–1378. doi: 10.1016/s0022-5347(17)53511-9. [DOI] [PubMed] [Google Scholar]
  12. Nicar M. J., Peterson R., Pak C. Y. Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J Urol. 1984 Mar;131(3):430–433. doi: 10.1016/s0022-5347(17)50438-3. [DOI] [PubMed] [Google Scholar]
  13. Nicar M. J., Skurla C., Sakhaee K., Pak C. Y. Low urinary citrate excretion in nephrolithiasis. Urology. 1983 Jan;21(1):8–14. doi: 10.1016/0090-4295(83)90113-9. [DOI] [PubMed] [Google Scholar]
  14. Pak C. Y., Fuller C. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med. 1986 Jan;104(1):33–37. doi: 10.7326/0003-4819-104-1-33. [DOI] [PubMed] [Google Scholar]
  15. Pak C. Y., Peterson R. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern Med. 1986 May;146(5):863–867. [PubMed] [Google Scholar]
  16. Pak C. Y., Sakhaee K., Fuller C. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int. 1986 Sep;30(3):422–428. doi: 10.1038/ki.1986.201. [DOI] [PubMed] [Google Scholar]
  17. Pak C. Y., Skurla C., Brinkley L., Sakhaee K. Augmentation of renal citrate excretion by oral potassium citrate administration: time course, dose frequency schedule, and dose-response relationship. J Clin Pharmacol. 1984 Jan;24(1):19–26. doi: 10.1002/j.1552-4604.1984.tb01809.x. [DOI] [PubMed] [Google Scholar]
  18. Parfitt A. M. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion. Arch Intern Med. 1969 Dec;124(6):736–740. [PubMed] [Google Scholar]
  19. Park G. D., Spector R. Hypocitraturic calcium-oxalate nephrolithiasis. Ann Intern Med. 1986 May;104(5):723–724. doi: 10.7326/0003-4819-104-5-723_2. [DOI] [PubMed] [Google Scholar]
  20. Parks J. H., Coe F. L. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul;30(1):85–90. doi: 10.1038/ki.1986.155. [DOI] [PubMed] [Google Scholar]
  21. Preminger G. M., Sakhaee K., Skurla C., Pak C. Y. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol. 1985 Jul;134(1):20–23. doi: 10.1016/s0022-5347(17)46963-1. [DOI] [PubMed] [Google Scholar]
  22. Pylypchuk G., Ehrig U., Wilson D. R. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation. Can Med Assoc J. 1979 Mar 17;120(6):658–665. [PMC free article] [PubMed] [Google Scholar]
  23. Robertson W. G., Peacock M., Nordin B. E. Activity products in stone-forming and non-stone-forming urine. Clin Sci. 1968 Jun;34(3):579–594. [PubMed] [Google Scholar]
  24. Rudman D., Dedonis J. L., Fountain M. T., Chandler J. B., Gerron G. G., Fleming G. A., Kutner M. H. Hypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med. 1980 Sep 18;303(12):657–661. doi: 10.1056/NEJM198009183031201. [DOI] [PubMed] [Google Scholar]
  25. Rudman D., Kutner M. H., Redd S. C., 2nd, Waters W. C., 4th, Gerron G. G., Bleier J. Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab. 1982 Dec;55(6):1052–1057. doi: 10.1210/jcem-55-6-1052. [DOI] [PubMed] [Google Scholar]
  26. Ryall R. L., Hibberd C. M., Marshall V. R. A method for studying inhibitory activity in whole urine. Urol Res. 1985;13(6):285–289. doi: 10.1007/BF00262658. [DOI] [PubMed] [Google Scholar]
  27. Sakhaee K., Nicar M., Hill K., Pak C. Y. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int. 1983 Sep;24(3):348–352. doi: 10.1038/ki.1983.165. [DOI] [PubMed] [Google Scholar]
  28. Schwille P. O., Scholz D., Schwille K., Leutschaft R., Goldberg I., Sigel A. Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic. Nephron. 1982;31(3):194–202. doi: 10.1159/000182646. [DOI] [PubMed] [Google Scholar]
  29. Simpson D. P. Citrate excretion: a window on renal metabolism. Am J Physiol. 1983 Mar;244(3):F223–F234. doi: 10.1152/ajprenal.1983.244.3.F223. [DOI] [PubMed] [Google Scholar]
  30. Weber D. V., Coe F. L., Parks J. H., Dunn M. S., Tembe V. Urinary saturation measurements in calcium nephrolithiasis. Ann Intern Med. 1979 Feb;90(2):180–184. doi: 10.7326/0003-4819-90-2-180. [DOI] [PubMed] [Google Scholar]
  31. Welshman S. G., McGeown M. G. Urinary citrate excretion in stone-formers and normal controls. Br J Urol. 1976 Feb;48(1):7–11. doi: 10.1111/j.1464-410x.1976.tb02731.x. [DOI] [PubMed] [Google Scholar]
  32. Zerwekh J. E., Hwang T. I., Poindexter J., Hill K., Wendell G., Pak C. Y. Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors. Kidney Int. 1988 May;33(5):1005–1008. doi: 10.1038/ki.1988.100. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES